A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before surgery could help prolong their lives.
The black-white gap has closed considerably over the past several decades, a new report finds.
The American Cancer Society Cancer Action Network released a report that report examines the growing burden of cervical cancer in low- and middle-income countries around the world.
Caryn Lerman was named director at USC Norris Comprehensive Cancer Center, effective March 15.
St. Baldrick's Foundation and the American Cancer Society announced a partnership to raise $11 million to fund innovative biological and clinical laboratory studies focused on childhood cancer.
The American Cancer Society Cancer Action Network released a report that examines the growing burden of cervical cancer in low- and middle-income countries around the world.
The mathematical concepts underlying the challenge NCI is facing today aren't difficult to grasp. In fact, a 14-year-old in an algebra class should be able to get it, NCI Director Ned Sharpless said to the National Cancer Advisory Board Feb. 12.
FDA approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma who have been previously treated with sorafenib.
The EC has approved the combination of Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg for the first-line treatment of patients with intermediate- and poor-risk advanced renal cell carcinoma. This decision represents the first approval of an immuno-oncology combination therapy for patients with this type of cancer in the E.U.
QIAGEN announced the Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's Vizimpro (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer. The therascreen EGFR RGQ PCR Kit is registered in more than 40 countries globally. This marks the first companion diagnostic approval for QIAGEN in Japan.
